Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κB (NF-κB) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line

British Journal of Haematology

Volumn 110, Issue 1, 2000, Pages 130-134

  White, B ^a   Schmidt, M ^a   Murphy, C ^a   Livingstone, W ^a   O'Toole, D ^a   Lawler, M ^a   O'Neill, L ^a   Kelleher, D ^a   Schwarz, H P ^b   Smith, O P ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

NF B; Protein C; Sepsis; TNF

Indexed keywords

ACTIVATED PROTEIN C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; INTRACELLULAR TRANSPORT; MONOCYTE; PRIORITY JOURNAL; PROTEIN TRANSPORT; SEPSIS;

ANALYSIS OF VARIANCE; CELL LINE; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PROTEIN C; STATISTICS, NONPARAMETRIC; TRANSLOCATION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033880884     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02128.x     Document Type: Article

References (25)

1. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group
2. The NF-kappa B and I kappa B proteins: New discoveries and insights
3. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
4. Role of NFkappaB in the mortality of sepsis
5. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation
6. The regulation of natural anticoagulant pathways
7. Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein C
8. LPS-binding proteins and receptors
9. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester
10. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses
11. Identification of divalent metal ion-dependent inhibition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin
12. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production
13. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
14. Protein C in the treatment of coagulopathy in meningococcal disease
15. Treatment of purpura fulminans in meningococcemia with protein C concentrate
16. Structure, regulation and function of NF-kappa B
17. Infectious purpura fulminans: Diagnosis and treatment
18. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans [see comments]
19. Protein C inhibitor: Structure and function
20. C4b-binding protein exacerbates the host response to Escherichia coli
21. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: Regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor
22. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
23. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections
24. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1c-Jun, and NF-kappaB transcription factors
25. Transcriptional and post-transcriptional mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA